4.7 Article

Study of erdafitinib stress degradation behavior using HPLC-UV analysis and multistage fragmentation ion trap mass spectrometry

Related references

Note: Only part of the references are listed.
Article Biochemical Research Methods

HPLC-UV determination of erdafitinib in mouse plasma and its application to pharmacokinetic studies

Tarek Elawady et al.

Summary: Erdafitinib is a recently approved FGFR inhibitor for patients with metastatic bladder cancer. A validated HPLC-UV method was developed for the determination of erdafitinib in mouse plasma. The method was successfully applied to pharmacokinetic studies of the drug.

JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2021)

Article Chemistry, Analytical

LC-MS/MS determination of erdafitinib in human plasma after SPE: Investigation of the method greenness

Tarek Elawady et al.

MICROCHEMICAL JOURNAL (2020)

Review Oncology

Targeting FGFR Signaling in Cancer

Mehdi Touat et al.

CLINICAL CANCER RESEARCH (2015)